Shanghai, China

Yaer Hu

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yaer Hu. Retrieved from https://idiyas.com/inventor/yaer-hu-13qyiugn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yaer Hu in Cognitive Dysfunction Treatment

Introduction

Yaer Hu is an accomplished inventor based in Shanghai, China. He has made significant contributions to the field of cognitive dysfunction treatment through his innovative research and patenting efforts. His work focuses on the therapeutic applications of smilagenin, a compound that shows promise in addressing cognitive impairments.

Latest Patents

Yaer Hu holds a patent for "Smilagenin and its use." This invention discloses the application of smilagenin in the treatment of cognitive dysfunction and similar conditions. The patent outlines various methods of treatment and pharmaceutical compositions that utilize this compound, showcasing Hu's commitment to advancing medical science.

Career Highlights

Throughout his career, Yaer Hu has demonstrated a strong dedication to research and innovation. His work has led to the development of novel therapeutic approaches that could potentially improve the quality of life for individuals suffering from cognitive disorders. With a patent portfolio that includes 1 patent, Hu is recognized for his contributions to the field.

Collaborations

Yaer Hu has collaborated with notable colleagues, including Zongqin Xia and Ian Duncan Rubin. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in cognitive health.

Conclusion

Yaer Hu's innovative work in the treatment of cognitive dysfunction through the use of smilagenin highlights his role as a significant contributor to medical research. His patent and collaborations reflect a commitment to improving therapeutic options for those affected by cognitive impairments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…